Ginkgo Bioworks Holdings ($DNA) Insider Trading & Smart Money Activity

Ginkgo Bioworks Holdings, Inc. · Biotechnology · Latest filing Oct 16, 2026

Ginkgo Bioworks Holdings, Inc. ($DNA) has 2 insider trades and 3 13F position changes on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($36.05K), net -$36.05K.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
1
Net insider $ (12 mo)
-$36.05K
Congress trades (12 mo)
0
13F moves on file
3
Analyst ratings on file
0

DNA insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 2
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 1 · $36.05K 0 / 0 0 / 1

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All DNA insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
13F Forbes J M Reduced -22.54K sh $12.54M —
Insider Coen Steven P.Chief Financial Officer Sell (Open-market sale) 10b5-1 2.40K sh $36.05K -21.3% —
Insider Christian Henry Buy (Grant or award) 25K sh +14.6%+13.1% Read
13F Belvedere Trading Sold out -177 sh -11.8%-4.1% —
13F Belvedere Trading Sold out -177 sh -11.8%-4.1% —

1W / 1M / 6M = how DNA moved from the trade or filing date.

Insider trading in DNA: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Coen Steven P. Chief Financial Officer 1 -$36.05K Oct 5, 2026
Christian Henry 1 — Jun 11, 2026

Institutions moving DNA (13F)

Frequently asked questions

Are DNA insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 1 open-market sale worth $36.05K, a net -$36.05K.

What is the latest insider trade in DNA?

Coen Steven P., Chief Financial Officer filed a sell (open-market sale) of 2.40K sh worth $36.05K on Oct 5, 2026.

Which institutions changed their DNA positions?

Recent 13F filers moving the stock include Belvedere Trading and Forbes J M.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text